Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DNA · as of Mar 31, 2025
Ownership Breakdown
174
Institutional Holders
▼ 7 vs Q4
$183.96M
Total Inst. Value
▼ $134.95M vs Q4
65.32M
Shares Outstanding
freeFloat 73.25%
32.27M
13F Shares Held
▼ 232,940 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DNA largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP biological products, (no diagnostic substances) | 3.58M | 6.59% | 6.59% | $20.39B | May 15, 2025 | — held |
BAILLIE GIFFORD & CO biological products, (no diagnostic substances) | 3.35M | 6.18% | 6.18% | $19.10B | May 7, 2025 | ▼ 6.5K |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 2.13M | 3.93% | 3.93% | $12.15B | May 9, 2025 | ▲ 117.4K |
ANCHORAGE CAPITAL GROUP, L.L.C. biological products, (no diagnostic substances) | 1.75M | 3.22% | 3.22% | $9.95B | May 15, 2025 | — held |
ERSTE ASSET MANAGEMENT GMBH biological products, (no diagnostic substances) | 1.65M | 3.04% | 3.04% | $9.40B | May 14, 2025 | ▲ 910.7K |
ECOR1 CAPITAL, LLC biological products, (no diagnostic substances) | 1.46M | 2.70% | 2.70% | $8.34B | May 15, 2025 | ▼ 281.0K |
MILLENNIUM MANAGEMENT LLC biological products, (no diagnostic substances) | 1.43M | 2.63% | 2.63% | $8.14B | May 15, 2025 | ▲ 757.5K |
LEGAL & GENERAL GROUP PLC biological products, (no diagnostic substances) | 1.42M | 2.62% | 2.62% | $8.09B | May 15, 2025 | ▲ 567.2K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 1.24M | 2.29% | 2.29% | $7.08B | May 2, 2025 | ▼ 46.6K |
OPALEYE MANAGEMENT INC. biological products, (no diagnostic substances) | 1.20M | 2.20% | 2.20% | $6.81B | May 15, 2025 | ▼ 5.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+4.90M shares2
New Positions
first time holders14
Decreased
−4.12M shares0
Sold Out
fully exitedNet shares change (top 50)
+784.2K
+4.90M / −4.12M
Net new holders
+14
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DNA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
18
Sell transactions
0.56
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Coen Steven P. See remarks | May 22, 2026 | Sale | 307 | $8.33 | $2.6K | 50.7K | Form 4 ↗ |
Coen Steven P. See remarks | Apr 17, 2026 | Sale | 324 | $7.95 | $2.6K | 50.3K | Form 4 ↗ |
Coen Steven P. See remarks | Apr 13, 2026 | Sale | 33,171 | $6.41 | $212.8K | 49.8K | Form 4 ↗ |
Canton Barry 10 percent owner | Apr 10, 2026 | Sale | 124,727 | $6.43 | $802.5K | 436.4K | Form 4 ↗ |
Shetty Reshma P. See remarks | Apr 10, 2026 | Sale | 124,727 | $6.43 | $802.5K | 436.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ginkgo Bioworks Holdings, Inc. (DNA) is primarily owned by institutional investors, who hold approximately 49.4% of total shares outstanding. Company insiders own approximately 26.75%, while retail and public investors account for the remaining 23.85%.
The largest institutional shareholder of Ginkgo Bioworks Holdings, Inc. is VIKING GLOBAL INVESTORS LP, holding approximately 3.58 million shares — equal to 6.59% of outstanding shares — as of March 31, 2025.
A total of 174 institutional investors currently hold DNA stock, with a combined institutional value of approximately $183,955,088 as of the most recent 13F filing period.
Frequently asked questions
DNA ownershipGinkgo Bioworks Holdings, Inc. (DNA) is primarily owned by institutional investors, who hold approximately 49.4% of shares. The largest shareholder is VIKING GLOBAL INVESTORS LP with a 6.59% stake. Company insiders hold 26.75%. Data sourced from SEC Form 13F as of March 31, 2025.